| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |